Friday, March 07, 2025 | 03:23 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 7 - Serum Institute Of India

Novavax, SII apply to WHO for emergency use listing of Covid vaccine

Novavax Inc and its partner Serum Institute of India on Thursday said they have submitted an application to the World Health Organization for emergency use listing (EUL) of Novavax's COVID-19 vaccine.

Novavax, SII apply to WHO for emergency use listing of Covid vaccine
Updated On : 23 Sep 2021 | 10:06 PM IST

SII to supply nearly 220 mn doses of Covishield vaccine to Centre in Oct

The Serum Institute of India has informed the Centre that it will be able to supply around 22 crore doses of Covishield in October

SII to supply nearly 220 mn doses of Covishield vaccine to Centre in Oct
Updated On : 21 Sep 2021 | 7:05 PM IST

Time is right: Why India still has 12-16 weeks between Covishield doses

Difference between the effectiveness of a single dose versus two doses is not that large for protection from hospitalisation and severe disease.

Time is right: Why India still has 12-16 weeks between Covishield doses
Updated On : 21 Sep 2021 | 8:48 AM IST

India to resume export of Covid vaccines from October: Mansukh Mandaviya

Sources say the Centre has been working to create a stockpile of vaccines for India in case a third wave strikes

India to resume export of Covid vaccines from October: Mansukh Mandaviya
Updated On : 21 Sep 2021 | 12:59 AM IST

Centre orders 660 mn Covishield doses, to be supplied by Dec: Report

The Union government has placed a purchase order with the Serum Institute of India (SII) for 66 crore doses of Covishield to be supplied by December, official sources said on Thursday. The development comes after Prakash Kumar Singh, the Director, Government and Regulatory Affairs at SII, informed the Union Health Ministry that the firm would be able to supply 20.29 crore doses of Covishied in the month of September. The Pune-based firm has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month. The Health Ministry had in July placed an order with Bharat Biotech for the supply of 28.50 crore doses of Covaxin, but the firm has not been able to start the supply of those yet, an official source said. Bharat Biotech is close to completing the supply of five crore doses of Covaxin for which the Health Ministry had placed an order on March 12, the source said. The source added that the ministry had placed an order for 37.50 crore doses of Covishield betw

Centre orders 660 mn Covishield doses, to be supplied by Dec: Report
Updated On : 09 Sep 2021 | 7:08 PM IST

Allow second Covishield dose after 4 weeks from first: Kerala HC to Centre

The Kerala High Court has directed the Centre to allow scheduling, on CoWIN portal, of second COVISHIELD dose after four weeks from the first for those who want to take it earlier

Allow second Covishield dose after 4 weeks from first: Kerala HC to Centre
Updated On : 07 Sep 2021 | 1:26 AM IST

Kerala HC allows Covishield second jab after 28 days in pvt sector

In a crucial intervention, the Kerala High Court on Monday ruled that the second dose of Covishield can be taken 28 days of taking the first dose in the private sector

Kerala HC allows Covishield second jab after 28 days in pvt sector
Updated On : 06 Sep 2021 | 8:52 PM IST

India's coronavirus vaccine supply jumps, raising hopes of export

After donating or selling 66 million doses to nearly 100 countries, India barred exports in the middle of April to focus on domestic immunisation as infections exploded

India's coronavirus vaccine supply jumps, raising hopes of export
Updated On : 30 Aug 2021 | 12:33 PM IST

No plan yet to revise Covishield 84-day dose gap, clarifies govt

Earlier there were reports that government could make a move to reduce the minimum gap between two doses of the Covishield Covid-19 vaccine, but NTAGI has denied the reports

No plan yet to revise Covishield 84-day dose gap, clarifies govt
Updated On : 26 Aug 2021 | 8:26 PM IST

SII informs Centre it will supply around 200 mn Covishield doses in Sep

SII has informed the Centre that it will be able to supply around 20 crore doses of COVID-19 vaccine Covishield in September itself to Government to India and private hospitals, official sources said

SII informs Centre it will supply around 200 mn Covishield doses in Sep
Updated On : 26 Aug 2021 | 5:39 PM IST

Serum Institute picks up 50% in glass vial maker Schott's Indian JV

Deal value not disclosed; former co-promoters Kaisha exits JV

Serum Institute picks up 50% in glass vial maker Schott's Indian JV
Updated On : 17 Aug 2021 | 11:03 PM IST

India's Serum Institute takes 50% stake in drug vial maker Schott Kaisha

SII, the world's largest vaccine maker by production volume, has taken a 50% stake in Indian drug vial maker Schott Kaisha, the companies said in a statement on Tuesday.

India's Serum Institute takes 50% stake in drug vial maker Schott Kaisha
Updated On : 17 Aug 2021 | 2:20 PM IST

Serum Institute buys 50% stake in pharma packaging firm Schott Kaisha

The joint venture is for pharmaceutical packaging

Serum Institute buys 50% stake in pharma packaging firm Schott Kaisha
Updated On : 17 Aug 2021 | 2:14 PM IST

Serum chairman Cyrus Poonawalla against using cocktail of Covid vaccines

Serum Institute of India (SII) chairman Dr Cyrus Poonawalla on Friday said he was not in favour of administering two different coronavirus vaccines for better efficacy. Poonawalla, whose firm makes the Covishield vaccine, was speaking to reporters after receiving the Lokmanya Tilak National Award here. "I am against the mixing of two different vaccines. There is no need to mix two different vaccines," he said, when asked about a recent ICMR study that a cocktail of Covishield and Covaxin could generate better immunity. "If cocktail vaccines are administered and if the result is not good, then SII may say that another vaccine was not good, vice versa, the other company might say that since you mixed Serum's vaccine, it did not give desired results," Poonawalla said. The efficacy of this approach has not been proven in field trials involving thousands of participants, he added. A study by the Indian Council of Medical Research involving 98 people, 18 of whom had inadvertently ...

Serum chairman Cyrus Poonawalla against using cocktail of Covid vaccines
Updated On : 13 Aug 2021 | 9:15 PM IST

Covid-19 vaccine export ban 'very bad' move: SII chairman Cyrus Poonawalla

Cyrus Poonawalla, chairman of SII, on Friday termed the ban on Covid-19 vaccine exports imposed by the Union government a very bad move, saying it put his company,in a difficult situation

Covid-19 vaccine export ban 'very bad' move: SII chairman Cyrus Poonawalla
Updated On : 13 Aug 2021 | 8:41 PM IST

Bureaucratic red tape, licence raj came down under Modi govt: SII chairman

Chairman of vaccine maker Serum Institute of India (SII), Dr Cyrus Poonawalla, on Friday hailed the Modi government saying that red-tapism and licence raj have come down under its rule.

Bureaucratic red tape, licence raj came down under Modi govt: SII chairman
Updated On : 13 Aug 2021 | 4:11 PM IST

Covid-19 pandemic: Novavax shot may get nod in India even before US

SII and Novavax have now completed submission of all modules required by regulatory agencies in India, Indonesia and the Philippines for the initiation of review of the vaccine

Covid-19 pandemic: Novavax shot may get nod in India even before US
Updated On : 11 Aug 2021 | 6:04 AM IST

Mixing Covaxin and Covishield safe, gives better immune response: ICMR

The study was conducted on 18 individuals who inadvertently received Covishield as first jab and Covaxin as second in UP at a gap of six weeks

Mixing Covaxin and Covishield safe, gives better immune response: ICMR
Updated On : 08 Aug 2021 | 11:27 PM IST

Covishield-Covaxin combination works better than 2 doses of same jab: ICMR

Study also found that the combination was safe and adverse effects were found to be similar when compared to the same-dose regimen

Covishield-Covaxin combination works better than 2 doses of same jab: ICMR
Updated On : 08 Aug 2021 | 2:21 PM IST

Hopeful of launching Covovax for adults in October this year: Serum CEO

Poonawalla met Home Minister Amit Shah in Parliament and the meeting between the two lasted for 30 minutes.

Hopeful of launching Covovax for adults in October this year: Serum CEO
Updated On : 06 Aug 2021 | 11:20 PM IST